Market Outlook
The Egypt pharmaceutical market was valued at USD 1,204.09 million in 2023 and is expected to witness robust growth over the forecast period, registering a compound annual growth rate (CAGR) of 6.45% through 2029.
The Egypt pharmaceutical market demonstrates significant potential for growth, driven by a combination of demographic, economic, and policy-related factors. With a population exceeding 100 million, Egypt represents the largest consumer base in the Middle East and North Afr